Leukemia  >>  hydrocortisone  >>  Phase 4
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
hydrocortisone / Generic mfg.
2017-002738-22: DexaDays-2 study DexaDagen-2 studie

 
4
150
Europe
Hydrocortisone, not applicable, Oral solution
Princess Máxima Center of Pediatric Oncology, KiKa
Acute lymphoblastic leukemia Acute lymfatische leukemie, Blood cancer Bloedkanker, Diseases [C] - Cancer [C04]
 
 
NCT00526305: LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive

Completed
4
100
Europe
Vincristine, Daunorubicin, Prednisone, L-Asparaginase, Mitoxantrone, Cytosine Arabinoside, Hydrocortisone, Mercaptopurine, Cyclophosphamide, Dexamethasone
PETHEMA Foundation
Acute Lymphoblastic Leukemia
04/05
04/05
ALL-AR-03, NCT00853008: Treatment of High Risk Adult Acute Lymphoblastic Leukemia

Completed
4
100
Europe
Vincristine, Daunorubicin, Prednisone, Mitoxantrone, Cytosine Arabinoside, Dexamethasone, Methotrexate (MTX), Cytarabine, ASP, Mercaptopurine, Teniposide, Hydrocortisone
PETHEMA Foundation
Acute Lymphoblastic Leukemia
11/12
12/12
NCT06289673: Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

Not yet recruiting
4
850
US
Dexamethasone, Decadron, Vincristine, Vincristine Sulfate, Oncovin, Daunorubicin, Daunomycin, Intrathecal triple therapy (methotrexate + hydrocortisone + cytarabine), ITMHA, Methotrexate, MTX, Trexall®, Cytarabine, Cytosine arabinoside, Ara-C
St. Jude Children's Research Hospital
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Mixed Phenotype Acute Leukemia
05/34
05/39

Download Options